Works by Duan, Xinsuo


Results: 6
    1
    2
    3
    4
    5
    6

    A multicentre randomized double-blind placebo-controlled phase III study of the efficacy and safety of xeligekimab (GR1501) in patients with moderate-to-severe plaque psoriasis.

    Published in:
    British Journal of Dermatology, 2024, v. 191, n. 3, p. 336, doi. 10.1093/bjd/ljae062
    By:
    • Cai, Lin;
    • Jiang, Congjun;
    • Zhang, Guoqiang;
    • Fang, Hong;
    • Wang, Jinyan;
    • Li, Yumei;
    • Xu, Hui;
    • Xiao, Rong;
    • Ding, Yangfeng;
    • Huang, Kun;
    • Zhang, Chunlei;
    • Zhang, Litao;
    • Chen, Bin;
    • Duan, Xinsuo;
    • Pan, Weili;
    • Han, Guangming;
    • Chen, Rongyi;
    • Liu, Lunfei;
    • Zhang, Shoumin;
    • Tao, Juan
    Publication type:
    Article